General Information of This Antibody
Antibody ID
ANI0BMZTB
Antibody Name
5T4_0108
Antibody Type
Monoclonal antibody (mAb)
Antibody Subtype
Humanized IgG
Antigen Name
Trophoblast glycoprotein (TPBG)
 Antigen Info 
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
MEDI-0641 [Clinical candidate]
Discovered Using Cell Line-derived Xenograft Model
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Tumor Growth Inhibition value (TGI) ≈ 91.30% (Day 49) Positive 5T4 expression (5T4+++/++)
Method Description
A single dose of 5T4-PBD was administrated at 0.1 and 0.3 mg/kg intravenously into nude mice.
In Vivo Model MDA-MB-361 CDX model
In Vitro Model Breast adenocarcinoma MDA-MB-361 cells CVCL_0620
References
Ref 1 Improved Therapeutic Window in BRCA-mutant Tumors with Antibody-linked Pyrrolobenzodiazepine Dimers with and without PARP Inhibition. Mol Cancer Ther. 2019 Jan;18(1):89-99. doi: 10.1158/1535-7163.MCT-18-0314. Epub 2018 Oct 23.

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.